State Street SPDR S&P Biotech ETF (XBI) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

11.47B

Fund Score

Key Statistics

Open

$162.74

High

$164.35

52 Wk High

$169.89

AUM

11.47B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

3.81M

Market Cap

$16.24B

Mgmt Fee

0.35%

P/E Ratio

16.81

Prev. Close

$164.38

Low

$162.51

52 Wk Low

$92.49

Shares Out

75.22M

Yield

0.35%

Div. Freq

Avg. Volume Daily

8.12M

Beta

0.84

Avg. Expense Ratio

0.35%

P/B Ratio

4.53

Recent SPDR Series Trust - SPDR S&P Biotech ETF News

What's Going On With Novavax Stock?

Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as traders weigh updated autumn vaccine authorizations against the company's broader strategic pivot toward licensing and cost-structure optimization.

Henry Khederian

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.

Chandrima Sanyal

Novavax Stock Climbs Monday: What's Going On?

Shares of Novavax are trading higher Monday, extending its 30% monthly gains on COVID-19 vaccine approvals and broader biotech strength.

Henry Khederian

QUICK SPARK: $3.8B SPY Exodus Meets $3.7B QQQ Inflow in One Day

QQQ attracted $3.67 billion in ETF inflows while SPY saw $3.82 billion in outflows, as semiconductor ETFs also drew strong investor demand.

Chandrima Sanyal

Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

MRK, MRNA's cancer vaccine breakthrough could revive the mRNA trade, putting biotech and genomics ETFs back in focus.

Chandrima Sanyal

FAQ

How do I buy State Street SPDR S&P Biotech ETF (XBI) stock?

You can purchase shares of State Street SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.

View our list of the best stock brokerages

Who are State Street SPDR S&P Biotech ETF (XBI) competitors?

There are no as such competitors for State Street SPDR S&P Biotech ETF.

What is the forecast, or price target, for State Street SPDR S&P Biotech ETF (XBI) stock?

There is no analysis for State Street SPDR S&P Biotech ETF to provide a consensus price target.

What is the current price for State Street SPDR S&P Biotech ETF (XBI)?

The stock price for State Street SPDR S&P Biotech ETF (ARCA: XBI) is $163.4 last updated September 4, 2026 at 7:25 PM EDT.

Does State Street SPDR S&P Biotech ETF (XBI) pay a dividend?

There are no upcoming dividends for State Street SPDR S&P Biotech ETF.

When is State Street SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?

State Street SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.

Is State Street SPDR S&P Biotech ETF (XBI) going to split?

There is no upcoming split for State Street SPDR S&P Biotech ETF.

Key Statistics

Open

$162.74

High

$164.35

52 Wk High

$169.89

AUM

11.47B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

3.81M

Market Cap

$16.24B

Mgmt Fee

0.35%

P/E Ratio

16.81

Prev. Close

$164.38

Low

$162.51

52 Wk Low

$92.49

Shares Out

75.22M

Yield

0.35%

Div. Freq

Avg. Volume Daily

8.12M

Beta

0.84

Avg. Expense Ratio

0.35%

P/B Ratio

4.53

About

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Blend
Fund Inception	Jan 31, 2006
Managers	Raymond Donofrio Karl A. Schneider
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Top ETF Holdings

Symbol	Name	Share %
APGE	Apogee Therapeutics In...	1.60%
TWST	Twist Bioscience Corp.	1.44%
KYMR	Kymera Therapeutics In...	1.31%
ERAS	Erasca Inc.	1.35%
RVMD	Revolution Medicines I...	1.32%
ORKA	Oruka Therapeutics Inc...	1.51%
DNTH	Dianthus Therapeutics ...	1.42%
SYRE	Spyre Therapeutics Inc	1.37%
COGT	Cogent Biosciences Inc	1.34%
CGON	Cg Oncology Inc	1.28%